NA Travel Vaccine Market - Industry Trends and Forecast to 2035

Published Mar 01, 2024

Length 238 Pages

SKU # DAABD18750565

Description

NA Travel Vaccine Market - Industry Trends and Forecast to 2035

North America travel vaccine market is expected to reach USD 3,999,023.57 thousand by 2032 from USD 1,743,097.85 thousand in 2023, growing at a substantial CAGR of 9.8% in the forecast period of 2024 to 2032.

Market Segmentation:

By Composition (Combination Vaccines and Mono Vaccines), Type (Inactivated Vaccines, Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, and Viral Vector Vaccines), Category (Recommended Vaccine, Routine Vaccine and Required Vaccine), Disease (Typhoid, Hepatitis, Cholera, Varicella, Influenza, Japanese Encephalitis, Meningococcal Meningitis, Yellow Fever, Rabies, DPT, Measles and Mumps, Tick-Borne Encephalitis, Malaria, Covid-19, Polio and Others), Route of Administration (Injectable and Oral), Gender (Male and Female), Patient Type (Adult, Pediatric and Geriatric), Age Group (20-50 Years, Less than 20 Years and Above 50 Years), Distribution Channel (B2B and B2C), Countries (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2032

Some of the major factors contributing to the growth of the North America travel vaccines market are:

Driver
• Rising incidence of infectious diseases
Restraint
• High cost of travel vaccines
Opportunity
• Advancements in vaccine technology
Market Players
Some major companies dealing in the North America travel vaccines market are:
• GSK plc.
• Bavarian Nordic
• Pfizer Inc.
• Abbott
• CSL
• AstraZeneca
• Sanofi
• Merck & Co., Inc.
• Valneva SE
• Johnson & Johnson Services Inc.
• Dynavax Technologies.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of North America Travel Vaccines Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Product Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market Application Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces; 4.3 Pipeline Analysis
5 Market Overview: 5.1 Drivers; 5.1.1 Rising Incidence Of Infectious Diseases; 5.1.2 Increasing Travel And Tourism; 5.1.3 Government Regulations And Recommendations Regarding Vaccination; 5.1.4 Expansion Of Travel Medicine Clinics; 5.2 Restraints; 5.2.1 High Cost Of Travel Vaccines; 5.2.2 Regulatory Hurdles For Approval; 5.3 Opportunities; 5.3.1 Advancements In Vaccine Technology; 5.3.2 Growing Awareness Regarding Vaccines; 5.3.3 Integration Of Digital Health Solutions; 5.4 Challenges; 5.4.1 Cold Chain Requirements For Storage; 5.4.2 Vaccine Hesitancy And Misinformation
6 North America Travel Vaccine Market, By Composition: 6.1 Overview; 6.2 Combination Vaccines; 6.3 Mono Vaccines
7 North America Travel Vaccine Market, By Type: 7.1 Overview; 7.2 Inactivated Vaccines; 7.2.1 Hepatitis A; 7.2.2 Influenza; 7.2.3 Rabies; 7.2.4 Tick-borne Encephalitis; 7.2.5 Japanese Encephalitis; 7.2.6 Polio; 7.3 Subunit, Recombinant, Polysaccharide And Conjugate Vaccines; 7.3.1 Hepatitis B; 7.3.2 Meningococcal; 7.3.3 Malaria; 7.3.4 Covid-19; 7.4 Live-attenuated Vaccines; 7.4.1 Typhoid; 7.4.2 Cholera; 7.4.3 Yellow Fever; 7.4.4 Measles; 7.4.5 Mumps; 7.4.6 Rubella; 7.4.7 Varicella; 7.4.8 Others; 7.5 Toxoid Vaccines; 7.5.1 Diphtheria; 7.5.2 Tetanus; 7.6 Dna Vaccines; 7.7 Viral Vector Vaccines
8 North America Travel Vaccine Market, By Category: 8.1 Overview; 8.2 Recommended Vaccine; 8.2.1 Typhoid Fever Vaccines; 8.2.2 Hepatitis A; 8.2.3 Cholera; 8.2.4 Rabies; 8.2.5 Tick-borne Encephalitis; 8.2.6 Japanese Encephalitis; 8.2.7 Malaria; 8.2.8 Others; 8.3 Routine Vaccine; 8.3.1 Hepatitis B; 8.3.2 Influenza Vaccines; 8.3.3 Pneumococcal; 8.3.4 Diphtheria; 8.3.5 Tetanus; 8.3.6 Measles; 8.3.7 Mumps; 8.3.8 Rubella; 8.3.9 Pertussis; 8.3.10 Others; 8.4 Required Vaccine; 8.4.1 Yellow Fever; 8.4.2 Meningococcal; 8.4.3 Polio Vaccines
9 North America Travel Vaccine Market, By Disease: 9.1 Overview; 9.2 Typhoid; 9.3 Hepatitis; 9.3.1 Hepatitis A; 9.3.2 Hepatitis B; 9.4 Cholera; 9.5 Varicella; 9.6 Influenza; 9.7 Japanese Encephalitis; 9.8 Meningococcal Meningitis; 9.9 Yellow Fever; 9.10 Rabies; 9.11 Dpt; 9.12 Measles And Mumps; 9.13 Tick-borne Encephalitis; 9.14 Malaria; 9.15 Covid-19; 9.16 Polio; 9.17 Others
10 North America Travel Vaccine Market, By Route Of Administration: 10.1 Overview; 10.2 Injectable; 10.2.1 Intramuscular; 10.2.2 Subcutaneous; 10.2.3 Others; 10.3 Oral
11 North America Travel Vaccine Market, By Gender: 11.1 Overview; 11.2 Male; 11.3 Female
12 North America Travel Vaccine Market, By Patient Type: 12.1 Overview; 12.2 Adult; 12.3 Pediatric; 12.4 Geriatric
13 North America Travel Vaccine Market, By Age Group: 13.1 Overview; 13.2 20-50 Years; 13.3 Less Than 20 Years; 13.4 Above 50 Years
14 North America Travel Vaccine Market, By Distribution Channel: 14.1 Overview; 14.2 B2b; 14.3 B2c
15 North America Travel Vaccine Market, By Region: 15.1 North America; 15.1.1 U.S.; 15.1.2 Canada; 15.1.3 Mexico
16 North America Travel Vaccine Market: Company Landscape: 16.1 Company Share Analysis: North America
17 Swot Analysis
18 Company Profile: 18.1 Pfizer Inc.; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Development; 18.2 Sanofi; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Development; 18.3 Johnson & Johnson Services Inc.; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Developments; 18.4 Gsk Plc.; 18.4.1 Company Snapshot; 18.4.2 Revenue Analysis; 18.4.3 Company Share Analysis; 18.4.4 Product Portfolio; 18.4.5 Recent Development; 18.5 Merck & Co., Inc.; 18.5.1 Company Snapshot; 18.5.2 Revenue Analysis; 18.5.3 Company Share Analysis; 18.5.4 Product Portfolio; 18.5.5 Recent Development; 18.6 Abbott; 18.6.1 Company Snapshot; 18.6.2 Revenue Analysis; 18.6.3 Product Portfolio; 18.6.4 Recent Development; 18.7 Astrazeneca; 18.7.1 Company Snapshot; 18.7.2 Revenue Analysis; 18.7.3 Product Portfolio; 18.7.4 Recent Development; 18.8 Bavarian Nordic; 18.8.1 Company Snapshot; 18.8.2 Revenue Analysis; 18.8.3 Product Portfolio; 18.8.4 Recent Development; 18.9 Csl; 18.9.1 Company Snapshot; 18.9.2 Revenue Analysis; 18.9.3 Product Portfolio; 18.9.4 Recent Development; 18.10 Dynavax Technologies.; 18.10.1 Company Snapshot; 18.10.2 Revenue Analysis; 18.10.3 Product Portfolio; 18.10.4 Recent Developments; 18.11 Valneva Se; 18.11.1 Company Snapshot; 18.11.2 Revenue Analysis; 18.11.3 Product Portfolio; 18.11.4 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables: Table 1 Pipeline Analysis Of Travel Vaccines Market; Table 2 Vaccines Recommendation For International Travelers; Table 3 North America Travel Vaccine Market, By Composition, 2022-2032 (Usd Thousand); Table 4 North America Combination Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 5 North America Mono Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 6 North America Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 7 North America Inactivated Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 8 North America Inactivated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 9 North America Subunit, Recombinant, Polysaccharide And Conjugate Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 10 North America Subunit, Recombinant, Polysaccharide And Conjugate Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 11 North America Live-attenuated Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 12 North America Live-attenuated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 13 North America Toxoid Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 14 North America Toxoid Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 15 North America Dna Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 16 North America Viral Vector Vaccines In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 17 North America Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 18 North America Recommended Vaccine In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 19 North America Recommended Vaccines In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 20 North America Routine Vaccine In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 21 North America Routine Vaccines In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 22 North America Required Vaccine In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 23 North America Required Vaccines In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 24 North America Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 25 North America Typhoid In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 26 North America Hepatitis In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 27 North America Hepatitis In Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 28 North America Cholera In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 29 North America Varicella In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 30 North America Influenza In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 31 North America Japanese Encephalitis In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 32 North America Meningococcal Meningitis In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 33 North America Yellow Fever In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 34 North America Rabies In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 35 North America Dpt In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 36 North America Measles And Mumps In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 37 North America Tick-borne Encephalitis In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 38 North America Malaria In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 39 North America Covid-19 In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 40 North America Polio In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 41 North America Others In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 42 North America Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 43 North America Injectable In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 44 North America Injectable In Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 45 North America Oral In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 46 North America Travel Vaccine Market, By Gender, 2022-2032 (Usd Thousand); Table 47 North America Male In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 48 North America Female In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 49 North America Travel Vaccine Market, By Patient Type, 2022-2032 (Usd Thousand); Table 50 North America Adult In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 51 North America Pediatric In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 52 North America Geriatric In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 53 North America Travel Vaccine Market, By Age Group, 2022-2032 (Usd Thousand); Table 54 North America 20-50 Years In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 55 North America Less Than 20 Years In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 56 North America Above 50 Years In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 57 North America Travel Vaccine Market, By Distribution Channel, 2022-2032 (Usd Thousand); Table 58 North America B2b In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 59 North America B2c In Travel Vaccine Market, By Region, 2022-2032 (Usd Thousand); Table 60 North America Travel Vaccine Market, By Country, 2022-2032 (Usd Thousand); Table 61 North America Travel Vaccine Market, By Composition, 2022-2032 (Usd Thousand); Table 62 North America Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 63 North America Inactivated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 64 North America Subunit, Recombinant, Polysaccharide And Conjugate Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 65 North America Live-attenuated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 66 North America Toxoid Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 67 North America Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 68 North America Recommended Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 69 North America Routine Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 70 North America Required Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 71 North America Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 72 North America Hepatitis In Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 73 North America Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 74 North America Injectable In Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 75 North America Travel Vaccine Market, By Gender, 2022-2032 (Usd Thousand); Table 76 North America Travel Vaccine Market, By Patient Type, 2022-2032 (Usd Thousand); Table 77 North America Travel Vaccine Market, By Age Group, 2022-2032 (Usd Thousand); Table 78 North America Travel Vaccine Market, By Distribution Channel, 2022-2032 (Usd Thousand); Table 79 U.S. Travel Vaccine Market, By Composition, 2022-2032 (Usd Thousand); Table 80 U.S. Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 81 U.S. Inactivated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 82 U.S. Subunit, Recombinant, Polysaccharide And Conjugate Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 83 U.S. Live-attenuated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 84 U.S. Toxoid Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 85 U.S. Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 86 U.S. Recommended Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 87 U.S. Routine Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 88 U.S. Required Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 89 U.S. Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 90 U.S. Hepatitis In Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 91 U.S. Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 92 U.S. Injectable In Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 93 U.S. Travel Vaccine Market, By Gender, 2022-2032 (Usd Thousand); Table 94 U.S. Travel Vaccine Market, By Patient Type, 2022-2032 (Usd Thousand); Table 95 U.S. Travel Vaccine Market, By Age Group, 2022-2032 (Usd Thousand); Table 96 U.S. Travel Vaccine Market, By Distribution Channel, 2022-2032 (Usd Thousand); Table 97 Canada Travel Vaccine Market, By Composition, 2022-2032 (Usd Thousand); Table 98 Canada Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 99 Canada Inactivated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 100 Canada Subunit, Recombinant, Polysaccharide And Conjugate Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 101 Canada Live-attenuated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 102 Canada Toxoid Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 103 Canada Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 104 Canada Recommended Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 105 Canada Routine Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 106 Canada Required Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 107 Canada Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 108 Canada Hepatitis In Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 109 Canada Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 110 Canada Injectable In Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 111 Canada Travel Vaccine Market, By Gender, 2022-2032 (Usd Thousand); Table 112 Canada Travel Vaccine Market, By Patient Type, 2022-2032 (Usd Thousand); Table 113 Canada Travel Vaccine Market, By Age Group, 2022-2032 (Usd Thousand); Table 114 Canada Travel Vaccine Market, By Distribution Channel, 2022-2032 (Usd Thousand); Table 115 Mexico Travel Vaccine Market, By Composition, 2022-2032 (Usd Thousand); Table 116 Mexico Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 117 Mexico Inactivated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 118 Mexico Subunit, Recombinant, Polysaccharide And Conjugate Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 119 Mexico Live-attenuated Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 120 Mexico Toxoid Vaccines In Travel Vaccine Market, By Type, 2022-2032 (Usd Thousand); Table 121 Mexico Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 122 Mexico Recommended Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 123 Mexico Routine Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 124 Mexico Required Vaccine In Travel Vaccine Market, By Category, 2022-2032 (Usd Thousand); Table 125 Mexico Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 126 Mexico Hepatitis In Travel Vaccine Market, By Disease, 2022-2032 (Usd Thousand); Table 127 Mexico Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 128 Mexico Injectable In Travel Vaccine Market, By Route Of Administration, 2022-2032 (Usd Thousand); Table 129 Mexico Travel Vaccine Market, By Gender, 2022-2032 (Usd Thousand); Table 130 Mexico Travel Vaccine Market, By Patient Type, 2022-2032 (Usd Thousand); Table 131 Mexico Travel Vaccine Market, By Age Group, 2022-2032 (Usd Thousand); Table 132 Mexico Travel Vaccine Market, By Distribution Channel, 2022-2032 (Usd Thousand)
List Of Figures: Figure 1 North America Travel Vaccines Market: Segmentation; Figure 2 North America Travel Vaccines Market: Data Triangulation; Figure 3 North America Travel Vaccines Market: Droc Analysis; Figure 4 North America Travel Vaccines Market : North America Vs Regional Market Analysis; Figure 5 North America Travel Vaccines Market : Company Research Analysis; Figure 6 North America Travel Vaccines Market: Interview Demographics; Figure 7 North America Travel Vaccines Market: Dbmr Market Position Grid; Figure 8 North America Travel Vaccines Market: Market Application Coverage Grid; Figure 9 North America Travel Vaccines Market: Vendor Share Analysis; Figure 10 North America Travel Vaccines Market: Segmentation; Figure 11 Rising Awareness About The Importance Of Vaccination Among Travelers Are Expected To Drive The North America Travel Vaccines Market In The Forecast Period Of 2024 To 2032; Figure 12 Combination Vaccines Segment Is Expected To Account For The Largest Share Of The North America Travel Vaccines Market In 2021 & 2032; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of North America Travel Vaccine Market; Figure 14 North America Travel Vaccine Market: By Composition, 2023; Figure 15 North America Travel Vaccine Market: By Composition, 2024-2032 (Usd Thousand); Figure 16 North America Travel Vaccine Market: By Composition , Cagr (2024-2032); Figure 17 North America Travel Vaccine Market: By Composition, Lifeline Curve; Figure 18 North America Travel Vaccine Market: By Type, 2023; Figure 19 North America Travel Vaccine Market: By Type, 2024-2032 (Usd Thousand); Figure 20 North America Travel Vaccine Market: By Type, Cagr (2024-2032); Figure 21 North America Travel Vaccine Market: By Type, Lifeline Curve; Figure 22 North America Travel Vaccine Market: By Category, 2023; Figure 23 North America Travel Vaccine Market: By Category, 2024-2032 (Usd Thousand); Figure 24 North America Travel Vaccine Market: By Category, Cagr (2024-2032); Figure 25 North America Travel Vaccine Market: By Category, Lifeline Curve; Figure 26 North America Travel Vaccine Market: By Disease, 2023; Figure 27 North America Travel Vaccine Market: By Disease, 2024-2032 (Usd Thousand); Figure 28 North America Travel Vaccine Market: By Disease, Cagr (2024-2032); Figure 29 North America Travel Vaccine Market: By Disease, Lifeline Curve; Figure 30 North America Travel Vaccine Market: By Route Of Administration, 2023; Figure 31 North America Travel Vaccine Market: By Route Of Administration, 2024-2032 (Usd Thousand); Figure 32 North America Travel Vaccine Market: By Route Of Administration, Cagr (2024-2032); Figure 33 North America Travel Vaccine Market: By Route Of Administration, Lifeline Curve; Figure 34 North America Travel Vaccine Market: By Gender, 2023; Figure 35 North America Travel Vaccine Market: By Gender, 2024-2032 (Usd Thousand); Figure 36 North America Travel Vaccine Market: By Gender, Cagr (2024-2032); Figure 37 North America Travel Vaccine Market: By Gender, Lifeline Curve; Figure 38 North America Travel Vaccine Market: By Patient Type, 2023; Figure 39 North America Travel Vaccine Market: By Patient Type, 2024-2032 (Usd Thousand); Figure 40 North America Travel Vaccine Market: By Patient Type, Cagr (2024-2032); Figure 41 North America Travel Vaccine Market: By Patient Type, Lifeline Curve; Figure 42 North America Travel Vaccine Market: By Age Group, 2023; Figure 43 North America Travel Vaccine Market: By Age Group, 2024-2032 (Usd Thousand); Figure 44 North America Travel Vaccine Market: By Age Group, Cagr (2024-2032); Figure 45 North America Travel Vaccine Market: By Age Group, Lifeline Curve; Figure 46 North America Travel Vaccine Market: By Distribution Channel, 2023; Figure 47 North America Travel Vaccine Market: By Distribution Channel, 2024-2032 (Usd Thousand); Figure 48 North America Travel Vaccine Market: By Distribution Channel, Cagr (2024-2032); Figure 49 North America Travel Vaccine Market: By Distribution Channel, Lifeline Curve; Figure 50 North America Travel Vaccine Market: Snapshot (2023); Figure 51 North America Travel Vaccine Market: Company Share 2023 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now